Ixazomib is a proteasome inhibitor indicated in combination with lenalidomide (Revlimid\u00ae) and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.<\/p>\n
If ixazomib capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n","protected":false},"excerpt":{"rendered":"
Ixazomib is a medication used for the treatment of multiple myeloma.<\/p>\n
DISEASE INDICATIONS-Multiple Myeloma If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cixazomib capsules\u201d based on the information you provide.<\/p>\n
\nMANUFACTURER-Takeda Pharma A\/S
\nUSAGE-Oral
\nMEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada,
\nPharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n